title: Plasma exchange for hyperbilirubinemia following implantation of a left ventricle assist system: a case report.
abstract: A 49-year-old patient with end-stage dilated cardiomyopathy underwent implantation of a left ventricular assist system (LVAS). Although the systemic circulation seemed to be improved, the serum total bilirubin (Tbili) level increased sharply in the early postoperative period (preoperative Tbili, 5.7 mg/dl; postoperative day 3, 33.6 mg/dl). Plasma exchange (PE) was performed 7 times from postoperative day 4, and the Tbili level decreased to 16.3 mg/dl by postoperative day 11. Thereafter, serum Tbili normalized concomitant with improved circulatory condition. The cause of the hyperbilirubinemia was considered to be temporary right ventricular dysfunction or hepatic sinusoid endothelial dysfunction. The liver function was recoverable, so PE had been effective in this case. Unfortunately, the patient suffered a midbrain infarction and ultimately died. From this experience, PE is recommended if it is judged that liver function can be preserved and circulation is adequate, but its implementation should not be delayed. It is essential that LVAS is implanted before damage occurs to end-organ function and thus prevent hyperbilirubinemia.
authors.affiliation: Department of Surgery, Kurume University School of Medicine, Japan. eiki@med.kurume-u.ac.jp
authors.forename: E
authors.initials: E
authors.lastname: Tayama
authors.forename: H
authors.initials: H
authors.lastname: Kashikie
authors.forename: N
authors.initials: N
authors.lastname: Hayashida
authors.forename: S
authors.initials: S
authors.lastname: Fukunaga
authors.forename: S
authors.initials: S
authors.lastname: Chihara
authors.forename: S
authors.initials: S
authors.lastname: Yokose
authors.forename: T
authors.initials: T
authors.lastname: Kosuga
authors.forename: K
authors.initials: K
authors.lastname: Akasu
authors.forename: S
authors.initials: S
authors.lastname: Aoyogi
mesh_terms: D002311:Cardiomyopathy, Dilated / Q000150:complications* / Q000628:therapy*; D006353:Heart-Assist Devices; D006801:Humans; D006932:Hyperbilirubinemia / Q000209:etiology* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010951:Plasma Exchange